Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting

Objective: Methylphenidate extended-release orally disintegrating tablets (MPH XR-ODTs) represent a new technology for MPH delivery. ODTs disintegrate in the mouth without water and provide a pharmacokinetic profile that is consistent with once-daily dosing. This study sought to determine the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Childress, Ann C., Kollins, Scott H., Cutler, Andrew J., Marraffino, Andrea, Sikes, Carolyn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326982/
https://www.ncbi.nlm.nih.gov/pubmed/27183299
http://dx.doi.org/10.1089/cap.2016.0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326982/
https://www.ncbi.nlm.nih.gov/pubmed/27183299
http://dx.doi.org/10.1089/cap.2016.0002

Ejemplares similares